A Gilead Sciences-backed therapy made with a patient's own white blood cells shrank tumors in 62% of patients with recurrent ...

By Dennis Thompson HealthDay ReporterMONDAY, June 2, 2025 (HealthDay News) — U.S. rural communities could be experiencing a ...

A network of health professionals in south-west England that specialises in brain tumours has been recognised for its high ...

DJ Daniel, a 13-year-old with brain cancer, was diagnosed with new tumors but continues to inspire after being sworn in to ...

Pfizer's Depo-Provera shot has been linked to brain tumors — and hundreds of women are suing the pharmaceutical giant over it ...

A nurses’ union isn’t satisfied with a Mass General Brigham investigation that found the brain tumor cluster at ...

A shocking incident in St. Landry Parish has left a community in disbelief as a teacher is accused of stabbing a 6-year-old ...

A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing ...

ASCO heard data suggesting that cell therapy may be a way of treating glioblastoma, which has been long seen as incurable.

A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing ...

It was a sizeable one, as Dr. Clark Chen, the director of the brain tumor program at Brown University Health explained. "The tumor's located in a very important part of the brain that is in front of ...

A lab-designed molecule developed and extensively studied could represent a breakthrough in slowing tumor recurrence in glioblastoma, an aggressive and deadly form of brain cancer.